These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 36457846)

  • 21. The IGF2BP3/Notch/Jag1 pathway: A key regulator of hepatic stellate cell ferroptosis in liver fibrosis.
    Li X; Li Y; Zhang W; Jiang F; Lin L; Wang Y; Wu L; Zeng H; Zheng J
    Clin Transl Med; 2024 Aug; 14(8):e1793. PubMed ID: 39113232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
    Luo J; Yu H; Yuan Z; Ye T; Hu B
    Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer.
    Wu Q; Xie X; Huang Y; Meng S; Li Y; Wang H; Hu Y
    J Cancer; 2021; 12(3):682-692. PubMed ID: 33403026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. m
    Chen Y; Wang J; Xu D; Xiang Z; Ding J; Yang X; Li D; Han X
    Autophagy; 2021 Feb; 17(2):457-475. PubMed ID: 31983283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade.
    Han P; Wei S; Wang H; Cai Y
    Ann Hematol; 2024 Nov; 103(11):4511-4524. PubMed ID: 39264435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ZC3H13-Mediated m6A Modification Ameliorates Acute Myocardial Infarction through Preventing Inflammation, Oxidative Stress and Ferroptosis by Targeting lncRNA93358.
    Cai J; Wang X; Wang Z; Sheng S; Tang F; Zhang Z
    Inflammation; 2024 Aug; ():. PubMed ID: 39107569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
    Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
    Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
    Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
    Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA epigenetic modification: N6-methyladenosine.
    Zhang X; Jia GF
    Yi Chuan; 2016 Apr; 38(4):275-88. PubMed ID: 27103452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
    Teng Y; Zhao X; Xi Y; Fu N
    Cancer Biol Ther; 2023 Dec; 24(1):2249173. PubMed ID: 37700507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
    Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
    Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
    Paramasivam A; George R; Priyadharsini JV
    Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALKBH5 Modulates Asthma Progression by Downregulating N6-methyladenosine Methylation.
    Fan X; Wei C; Han Y
    Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):211-219. PubMed ID: 38822515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of N
    Lu Z; Ma Y; Li Q; Liu E; Jin M; Zhang L; Wei C
    Cell Stress Chaperones; 2019 Mar; 24(2):333-342. PubMed ID: 30701478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. METTL3 Reduces Oxidative Stress-induced Apoptosis in Presbycusis by Regulating the N6-methyladenosine Level of SIRT1 mRNA.
    Wang E; Li Y; Li H; Liu Y; Ming R; Wei J; Du P; Li X; Zong S; Xiao H
    Neuroscience; 2023 Jun; 521():110-122. PubMed ID: 37087022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.
    Zhu K; Gao T; Wang Z; Zhang L; Tan K; Lv Z
    Cell Death Discov; 2023 May; 9(1):151. PubMed ID: 37156775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.